A human interactome to prioritise drug discovery
Research highlights, Science Researchers create a network of interacting proteins – or interactome – to aid drug discovery.
2023
research-highlightsscience
Finding coronavirus’s helper proteins
Science A team of EMBL scientists and colleagues have analysed how the novel coronavirus affects proteins in human cells. They identified several human proteins as potential drug targets to prevent viral replication.
2021
science
Repurposing drugs for a pan-coronavirus treatment
Science Scientists from the Beltrao Group at EMBL-EBI and collaborators identified drug targets common to SARS-CoV-2, SARS-CoV-1, and MERS-CoV, three pathogenic coronaviruses. They also found potential drugs that could be repurposed as COVID-19 treatments, and against emerging coronavirus strains in the…
2020
science
Existing drugs can prevent SARS-CoV-2 from hijacking cells
Science Researchers evaluate how the new coronavirus rewires human proteins for its own replication, and identify several antiviral drugs ready for clinical trials
2020
science
Identifying how potential COVID-19 drugs work
Science EMBL researchers are studying how drugs that have shown good results against COVID-19 work in living cells
2020
science
Drivers of evolution hidden in plain sight
Science A rapid, versatile mechanism that modifies proteins is revealed to be crucial for the evolutionary process
2016
science
EMBL-EBI hosts the Cambridge New Therapeutics Forum
Events CamNTF hosts meetings around Cambridge, open to all scientists interested in new therapeutics
2016
events
See data in a new light
Science 3D printing, gaming, virtual reality and lenticular posters bring new perspectives to research
2016
science
No matching posts found
